StockWatch
·

Aarti Pharmalabs Ltd Q3 FY25 Results

AARTIPHARMQ3 FY25 Results
Filing
MetricValue (₹ Cr)vs Q2 FY25
Revenue537.7817.4%
Total Income542.8117.4%
Expenditure442.1813.2%
PBT100.6340.2%
Net Profit73.9935.5%
OPM11.64%2.71pp
NPM13.63%1.82pp
EPS8.1635.3%
View full financials

Informational and educational content only. Not investment advice.